Hayden Orgeron
Family · Humble, TXNPI 1457960759
Payments from drug & device makers
Across 392 payments — averaging $29.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Dermavant Sciences, Inc.$1K
- Johnson & Johnson$1K
- Sun Pharmaceutical Industries Inc.$856
- Novartis$828
- Lilly USA, LLC$760
- plus $5K from 22 others
What the payments were for
- Consulting fees$9308%
- Travel & lodging$90%
- Food & beverage$9,85286%
- Education$6336%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 65 | $1,373 |
| Dermavant Sciences, Inc. | 18 | $1,357 |
| Johnson & Johnson(2 entities) | 38 | $1,255 |
| Sun Pharmaceutical Industries Inc. | 25 | $856 |
| Novartis | 43 | $828 |
| Lilly USA, LLC | 27 | $760 |
| Sanofi | 29 | $754 |
| Arcutis Biotherapeutics, Inc. | 36 | $731 |
| Regeneron Healthcare Solutions, Inc. | 16 | $506 |
| Amgen | 16 | $349 |
| Journey Medical Corporation | 5 | $332 |
| Pfizer | 12 | $313 |
| E.r. Squibb & Sons, L.L.C. | 9 | $290 |
| VYNE Pharmaceuticals Inc. | 4 | $288 |
| Galderma Laboratories, L.p. | 13 | $260 |
| Organon | 8 | $164 |
| UCB, Inc. | 6 | $161 |
| Botanix SB Inc | 3 | $146 |
| Gilead | 1 | $125 |
| Stemline Therapeutics Inc. | 1 | $122 |
| Edwards Lifesciences | 1 | $101 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $98 |
| Scynexis, Inc. | 1 | $87 |
| LEO Pharma Inc. | 4 | $82 |
| Kyowa Kirin, Inc. | 2 | $30 |
| Boston Scientific | 1 | $26 |
| Verrica Pharmaceuticals Inc. | 1 | $19 |
| Mayne Pharma Commercial LLC | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,424 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 13 | $48,130 |
| Clobetasol Propionate | 90 | $3,502 |
| Azelaic Acid | 22 | $2,581 |
| Tacrolimus | 11 | $1,524 |
| Ketoconazole | 91 | $1,214 |
| Halobetasol Propionate | 17 | $1,139 |
| Triamcinolone Acetonide | 73 | $623 |
| Doxycycline Hyclate | 29 | $511 |
| Minoxidil | 19 | $331 |
| Minocycline Hcl | 14 | $312 |
| Levocetirizine Dihydrochloride | 21 | $264 |
| Mupirocin | 42 | $241 |
| Finasteride | 13 | $190 |
| Hydroxyzine Hcl | 16 | $163 |
Paid to pharmacies, not to this prescriber.
Other family in Humble
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
- Linda MercadoHouston$211K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.